U.S., Dec. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07267884) titled 'IABP for MI-VSD Patients in SCAI SHOCK Stage B' on Sept. 30.
Brief Summary: Ventricular septal defect (MI-VSD) is a serious mechanical complication of acute myocardial infarction, with an extremely high mortality. Intra-aortic balloon pump (IABP) is still the most easily available mechanical assistive device for clinical management, and it has become a bridge to surgical repair.
IABP-SHOCK II trial is currently the largest randomized controlled trial (RCT) related to the use of IABP among patients with acute myocardial infarction (AMI) complicated by cardiogenic shock (CS), the trial found that IABP had a negative impact on 30-day, ...